Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHID1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | MAP3K7 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | MRPL37 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | AC069499.1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | HSH2D | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | NRDC | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | SOD3 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | IMPDH2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | CHRNA5 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | DIP2B | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |